Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections

NCT02002377 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
23
Enrollment
OTHER
Sponsor class

Stopped Inadequate enrollment due to investigational product becoming newly available on the Canadian market soon after study start

Conditions

Interventions

Sponsor

Unity Health Toronto